$HCIL
Hongchang International Co., Ltd Stock $hcil

$hcil Overview Financials Valuation SEC Filings Company Website

2014 Q2 Form 10-Q Financial Statement

#000154812314000334 Filed on August 14, 2014

Income Statement

Concept	2014 Q2	2013 Q2
Revenue	$1.003M	$273.9K
YoY Change	266.11%	-3.96%
Cost Of Revenue	$605.8K	$107.5K
YoY Change	463.34%	104.78%
Gross Profit	$396.9K	$166.3K
YoY Change	138.62%	-28.5%
Gross Profit Margin	39.59%	60.74%
Selling, General & Admin	$480.7K	$329.8K
YoY Change	45.74%	0.4%
% of Gross Profit	121.1%	198.27%
Research & Development	$59.16K	$62.00K
YoY Change	-4.59%	21.17%
% of Gross Profit	14.9%	37.27%
Depreciation & Amortization	$0.00	$0.00
YoY Change		-100.0%
% of Gross Profit	0.0%	0.0%
Operating Expenses	$540.9K	$398.0K
YoY Change	35.91%	2.37%
Operating Profit	-$144.0K	-$231.6K
YoY Change	-37.85%	48.37%
Interest Expense	$3.050K	$8.715K
YoY Change	-65.0%	-74.74%
% of Operating Profit
Other Income/Expense, Net	$3.050K	$152.0K
YoY Change	-97.99%	1454.4%
Pretax Income	-$140.9K	-$79.63K
YoY Change	76.95%	-45.59%
Income Tax	$4.00	-$29.10K
% Of Pretax Income
Net Earnings	-$140.9K	-$50.53K
YoY Change	178.86%	-43.94%
Net Earnings / Revenue	-14.05%	-18.45%
Basic Earnings Per Share	$0.00	$0.00
Diluted Earnings Per Share	$0.00	$0.00
COMMON SHARES
Basic Shares Outstanding	49.71M shares	49.71M shares
Diluted Shares Outstanding	49.71M shares	49.71M shares

Balance Sheet

Concept	2014 Q2	2013 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.330M	$1.770M
YoY Change	-24.86%	205.17%
Cash & Equivalents	$1.326M	$1.765M
Short-Term Investments
Other Short-Term Assets	$20.00K	$20.00K
YoY Change	0.0%	100.0%
Inventory	$39.01K	$388.3K
Prepaid Expenses
Receivables	$473.6K	$71.52K
Other Receivables	$290.0K	$780.0K
Total Short-Term Assets	$2.141M	$3.029M
YoY Change	-29.3%	-15.51%
LONG-TERM ASSETS
Property, Plant & Equipment	$7.289K	$8.167K
YoY Change	-10.75%	-99.55%
Goodwill	$1.946M	$1.946M
YoY Change	0.0%	0.0%
Intangibles
YoY Change
Long-Term Investments		$290.0K
YoY Change		-49.12%
Other Assets	$440.0K	$2.780M
YoY Change	-84.17%	9.02%
Total Long-Term Assets	$2.392M	$5.021M
YoY Change	-52.36%	-26.82%
TOTAL ASSETS
Total Short-Term Assets	$2.141M	$3.029M
Total Long-Term Assets	$2.392M	$5.021M
Total Assets	$4.533M	$8.050M
YoY Change	-43.68%	-22.94%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$217.0K	$51.96K
YoY Change	317.68%	-49.24%
Accrued Expenses	$139.3K	$224.3K
YoY Change	-37.89%	-63.89%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$0.00	$10.00K
YoY Change	-100.0%
Total Short-Term Liabilities	$739.1K	$307.8K
YoY Change	140.11%	-66.42%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change		-100.0%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$739.1K	$307.8K
Total Long-Term Liabilities	$0.00
Total Liabilities	$740.0K	$307.8K
YoY Change	140.39%	-84.14%
SHAREHOLDERS EQUITY
Retained Earnings	-$14.33M	-$10.38M
YoY Change	38.04%	7.94%
Common Stock	$18.12M	$18.12M
YoY Change	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$3.794M	$7.742M
YoY Change
Total Liabilities & Shareholders Equity	$4.533M	$8.050M
YoY Change	-43.68%	-22.94%

Cashflow Statement

Concept	2014 Q2	2013 Q2
OPERATING ACTIVITIES
Net Income	-$140.9K	-$50.53K
YoY Change	178.86%	-43.94%
Depreciation, Depletion And Amortization	$0.00	$0.00
YoY Change		-100.0%
Cash From Operating Activities	-$270.0K	-$270.0K
YoY Change	0.0%	50.0%
INVESTING ACTIVITIES
Capital Expenditures		$0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$0.00	$510.0K
YoY Change	-100.0%	131.82%
Cash From Investing Activities	$0.00	$510.0K
YoY Change	-100.0%	131.82%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-20.00K	-10.00K
YoY Change	100.0%	0.0%
NET CHANGE
Cash From Operating Activities	-270.0K	-270.0K
Cash From Investing Activities	0.000	510.0K
Cash From Financing Activities	-20.00K	-10.00K
Net Change In Cash	-290.0K	230.0K
YoY Change	-226.09%	666.67%
FREE CASH FLOW
Cash From Operating Activities	-$270.0K	-$270.0K
Capital Expenditures		$0.00
Free Cash Flow		-$270.0K
YoY Change		50.0%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	us-gaap	Gains Losses On Sales Of Assets GainsLossesOnSalesOfAssets	143290	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	200780	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	10367	USD
	pweb	Segment Reporting Information Net Income Loss SegmentReportingInformationNetIncomeLoss	-404542	USD
	pweb	Segment Reporting Information Net Income Loss SegmentReportingInformationNetIncomeLoss	-138974	USD
CY2013Q2	pweb	Segment Reporting Information Net Income Loss SegmentReportingInformationNetIncomeLoss	-50532	USD
CY2014Q2	us-gaap	Revenues Revenues	1002711	USD
CY2014Q2	pweb	Segment Reporting Information Net Income Loss SegmentReportingInformationNetIncomeLoss	-140913	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1928821	USD
CY2013Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	USD
CY2014Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	USD
CY2013Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	88024	USD
CY2014Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	473575	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-7562	USD
CY2013Q2	us-gaap	Gains Losses On Sales Of Assets GainsLossesOnSalesOfAssets	143290	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	148024	USD
CY2014Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	18069715	USD
CY2013Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	48520	USD
CY2014Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	16264	USD
CY2013Q4	us-gaap	Inventory Net InventoryNet	22999	USD
CY2014Q2	us-gaap	Inventory Net InventoryNet	39009	USD
CY2013Q4	us-gaap	Assets Current AssetsCurrent	2368746	USD
CY2014Q2	us-gaap	Assets Current AssetsCurrent	2141181	USD
CY2013Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	9420	USD
CY2014Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7289	USD
CY2013Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	120676	USD
CY2014Q2	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	170669	USD
CY2013Q4	us-gaap	Security Deposit SecurityDeposit	4825	USD
CY2014Q2	us-gaap	Security Deposit SecurityDeposit	4825	USD
CY2013Q4	us-gaap	Goodwill Goodwill	1946253	USD
CY2014Q2	us-gaap	Goodwill Goodwill	1946253	USD
CY2013Q4	us-gaap	Assets Assets	4480014	USD
CY2014Q2	us-gaap	Assets Assets	4533347	USD
CY2013Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	47765	USD
CY2014Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	217024	USD
CY2013Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	146196	USD
CY2014Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	139304	USD
CY2013Q4	us-gaap	Notes Payable Current NotesPayableCurrent	25643	USD
CY2013Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	61661	USD
CY2014Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	382812	USD
CY2013Q4	us-gaap	Liabilities Current LiabilitiesCurrent	281265	USD
CY2014Q2	us-gaap	Liabilities Current LiabilitiesCurrent	739140	USD
CY2014Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2014Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2014Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	49713895	shares
CY2014Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	49713895	shares
CY2013Q4	us-gaap	Common Stock Value CommonStockValue	49714	USD
CY2014Q2	us-gaap	Common Stock Value CommonStockValue	49714	USD
CY2013Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	18069715	USD
CY2013Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-13920680	USD
CY2014Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-14325222	USD
CY2013Q4	us-gaap	Stockholders Equity StockholdersEquity	4198749	USD
CY2014Q2	us-gaap	Stockholders Equity StockholdersEquity	3794207	USD
CY2013Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4480014	USD
CY2014Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4533347	USD
CY2013Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	250000	USD
CY2014Q2	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	250000	USD
CY2013Q4	us-gaap	Interest Receivable Current InterestReceivableCurrent	30382	USD
CY2014Q2	us-gaap	Interest Receivable Current InterestReceivableCurrent	36667	USD
CY2013Q4	us-gaap	Deferred Costs DeferredCosts	30094	USD
CY2014Q2	us-gaap	Deferred Costs DeferredCosts	263130	USD
CY2014Q2	us-gaap	Notes Payable Current NotesPayableCurrent		USD
CY2013Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2013Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	49713895	shares
CY2013Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2013Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	49713895	shares
CY2012Q4	us-gaap	Loss Contingency Pending Claims Number LossContingencyPendingClaimsNumber	5	pure
CY2012Q4	us-gaap	Loss Contingency Range Of Possible Loss Maximum LossContingencyRangeOfPossibleLossMaximum	400000	USD
CY2011Q4	us-gaap	Loss Contingency Range Of Possible Loss Maximum LossContingencyRangeOfPossibleLossMaximum	400000	USD
CY2013	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	400000	USD
CY2013	us-gaap	Loss Contingency Damages Sought Value LossContingencyDamagesSoughtValue	300000	USD
	us-gaap	Technology Services Revenue TechnologyServicesRevenue	359813	USD
	us-gaap	Technology Services Revenue TechnologyServicesRevenue	1336226	USD
CY2013Q2	us-gaap	Technology Services Revenue TechnologyServicesRevenue	182299	USD
CY2014Q2	us-gaap	Technology Services Revenue TechnologyServicesRevenue	930250	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	141189	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	142649	USD
CY2013Q2	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	91581	USD
CY2014Q2	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	72461	USD
	us-gaap	Revenues Revenues	501002	USD
	us-gaap	Revenues Revenues	1478875	USD
CY2013Q2	us-gaap	Revenues Revenues	273880	USD
	us-gaap	Cost Of Revenue CostOfRevenue	159656	USD
	us-gaap	Cost Of Revenue CostOfRevenue	845780	USD
CY2013Q2	us-gaap	Cost Of Revenue CostOfRevenue	107534	USD
CY2014Q2	us-gaap	Cost Of Revenue CostOfRevenue	605778	USD
	us-gaap	Gross Profit GrossProfit	341346	USD
	us-gaap	Gross Profit GrossProfit	633095	USD
CY2013Q2	us-gaap	Gross Profit GrossProfit	166346	USD
CY2014Q2	us-gaap	Gross Profit GrossProfit	396933	USD
	us-gaap	Selling Expense SellingExpense	75128	USD
	us-gaap	Selling Expense SellingExpense	161797	USD
CY2013Q2	us-gaap	Selling Expense SellingExpense	52143	USD
CY2014Q2	us-gaap	Selling Expense SellingExpense	79377	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	120738	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	114089	USD
CY2013Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	62003	USD
CY2014Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	59155	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	506866	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	765699	USD
CY2013Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	277676	USD
CY2014Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	401295	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	14612	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2130	USD
CY2013Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	6161	USD
CY2014Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1065	USD
	us-gaap	Operating Expenses OperatingExpenses	717344	USD
	us-gaap	Operating Expenses OperatingExpenses	1043715	USD
CY2013Q2	us-gaap	Operating Expenses OperatingExpenses	397983	USD
CY2014Q2	us-gaap	Operating Expenses OperatingExpenses	540892	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-375998	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-410620	USD
CY2013Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-231637	USD
CY2014Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-143959	USD
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	10519	USD
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	6082	USD
CY2013Q2	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	8715	USD
CY2014Q2	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	3050	USD
CY2013Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	49713895	shares
CY2014Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
	us-gaap	Net Income Loss NetIncomeLoss	-138974	USD
	us-gaap	Net Income Loss NetIncomeLoss	-404542	USD
CY2013Q2	us-gaap	Net Income Loss NetIncomeLoss	-50532	USD
CY2014Q2	us-gaap	Net Income Loss NetIncomeLoss	-140913	USD
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	49713895	shares
CY2013Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	49713895	shares
CY2014Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	49713895	shares
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments		USD
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome		USD
	us-gaap	Gains Losses On Sales Of Assets GainsLossesOnSalesOfAssets		USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	6082	USD
CY2013Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	152005	USD
CY2014Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	3050	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-227974	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-404538	USD
CY2013Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-79632	USD
CY2014Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-140909	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-89000	USD
CY2013Q2	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-29100	USD
	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	4	USD
CY2014Q2	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	4	USD
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2013Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
CY2014Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	49713895	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	49713895	shares
CY2013Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	49713895	shares
CY2014Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	49713895	shares
CY2013Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments		USD
CY2013Q2	us-gaap	Other Nonoperating Income OtherNonoperatingIncome		USD
CY2014Q2	us-gaap	Gains Losses On Sales Of Assets GainsLossesOnSalesOfAssets		USD
CY2014Q2	us-gaap	Other Nonoperating Income OtherNonoperatingIncome		USD
CY2014Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments		USD
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome		USD
CY2011Q4	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	500000	USD
CY2011Q3	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	250000	USD
CY2011Q3	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	400000	USD
CY2011Q3	pweb	Receivable With Imputed Interest Fee Per Use ReceivableWithImputedInterestFeePerUse	3.00	USD
CY2011Q4	us-gaap	Long Term Investments LongTermInvestments	250000	USD
CY2011Q4	us-gaap	Equity Method Investment Ownership Percentage EquityMethodInvestmentOwnershipPercentage	0.25	pure
CY2012Q2	us-gaap	Long Term Investments LongTermInvestments	30000	USD
CY2012Q4	us-gaap	Long Term Investments LongTermInvestments	34500	USD
CY2013Q1	us-gaap	Long Term Investments LongTermInvestments	2000	USD
CY2013	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-210717	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	509023	USD
CY2014Q2	us-gaap	Debt Instrument Periodic Payment Principal DebtInstrumentPeriodicPaymentPrincipal	12821	USD
CY2014Q2	us-gaap	Debt Instrument Periodic Payment Interest DebtInstrumentPeriodicPaymentInterest	310	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	16010	USD
	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	6285	USD
	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	6285	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-403431	USD
CY2014Q2	pweb	Capital Call Provision Percent Of Investment CapitalCallProvisionPercentOfInvestment	0.40	pure
CY2014Q2	pweb	Capital Call Provision Conversion Ratio Failed Requirement CapitalCallProvisionConversionRatioFailedRequirement	2	pure
CY2014Q2	pweb	Capital Call Provision Conversion Ratio One CapitalCallProvisionConversionRatioOne	1	pure
CY2014Q2	pweb	Capital Call Provision Percent Of Investment Two CapitalCallProvisionPercentOfInvestmentTwo	0.30	pure
CY2014Q2	pweb	Capital Call Provision Membership Voting Interest Approval Percentage CapitalCallProvisionMembershipVotingInterestApprovalPercentage	0.75	pure
CY2014Q2	pweb	Monthly Payments Under Operating Lease Agreement Year One MonthlyPaymentsUnderOperatingLeaseAgreementYearOne	4300	USD
CY2014Q2	pweb	Monthly Payments Under Operating Lease Agreement Year Two MonthlyPaymentsUnderOperatingLeaseAgreementYearTwo	4425	USD
CY2014Q2	pweb	Monthly Payments Under Operating Lease Agreement Year Three MonthlyPaymentsUnderOperatingLeaseAgreementYearThree	4550	USD
CY2014Q2	pweb	Monthly Payments Under Operating Lease Agreement Year Four MonthlyPaymentsUnderOperatingLeaseAgreementYearFour	4700	USD
CY2014Q2	pweb	Monthly Payments Under Operating Lease Agreement Year Fifth MonthlyPaymentsUnderOperatingLeaseAgreementYearFifth	4825	USD
	us-gaap	Lease Expiration Date1 LeaseExpirationDate1	2018-05-31
CY2014Q2	pweb	Capital Call Provision Conversion Ratio CapitalCallProvisionConversionRatio	0.1712	pure
CY2013	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	1850000	USD
CY2013	us-gaap	Proceeds From Repayments Of Debt ProceedsFromRepaymentsOfDebt	1340597	USD
CY2013	us-gaap	Gains Losses On Sales Of Assets GainsLossesOnSalesOfAssets	143290	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-5785	USD
	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	89000	USD
	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	4825	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	19967	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	385551	USD
	us-gaap	Increase Decrease In Restricted Cash For Operating Activities IncreaseDecreaseInRestrictedCashForOperatingActivities	-411486	USD
	us-gaap	Increase Decrease In Restricted Cash For Operating Activities IncreaseDecreaseInRestrictedCashForOperatingActivities	49993	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	17167	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	162367	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	11328	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	321151	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-390095	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-577513	USD
	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	2000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	507023	USD
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	7562	USD
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	25642	USD
	us-gaap	Interest Paid InterestPaid	620	USD
	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes		USD
	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets		USD
	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments		USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment		USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid		USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid		USD
	dei	Entity Registrant Name EntityRegistrantName	PACIFIC WEBWORKS INC
	dei	Entity Central Index Key EntityCentralIndexKey	0001086303
	dei	Document Type DocumentType	10-Q
	dei	Document Period End Date DocumentPeriodEndDate	2014-06-30
	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Company
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2014
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
CY2014Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	49713895	shares
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-25642	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	109366	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-603155	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1655801	USD
CY2013Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1765167	USD
CY2014Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1325666	USD
	us-gaap	Interest Paid InterestPaid	341	USD
CY2011Q3	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	400000	USD
CY2011Q3	us-gaap	Related Party Transaction Rate RelatedPartyTransactionRate	0.15	pure

Files In Submission

Name	View Source	Status
0001548123-14-000334-index-headers.html	Edgar Link	pending
0001548123-14-000334-index.html	Edgar Link	pending
0001548123-14-000334.txt	Edgar Link	pending
0001548123-14-000334-xbrl.zip	Edgar Link	pending
ex311.htm	Edgar Link	pending
ex312.htm	Edgar Link	pending
ex32.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
pweb-20140630.xml	Edgar Link	completed
pweb-20140630.xsd	Edgar Link	pending
pweb-20140630_cal.xml	Edgar Link	unprocessable
pweb-20140630_def.xml	Edgar Link	unprocessable
pweb-20140630_lab.xml	Edgar Link	unprocessable
pweb-20140630_pre.xml	Edgar Link	unprocessable
pweb_201410qq2v5.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$HCIL
Hongchang International Co., Ltd Stock $hcil

2014 Q2 Form 10-Q Financial Statement

#000154812314000334 Filed on August 14, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HCIL Hongchang International Co., Ltd Stock $hcil

2014 Q2 Form 10-Q Financial Statement

#000154812314000334 Filed on August 14, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HCIL
Hongchang International Co., Ltd Stock $hcil